LENZ
LENZ Therapeutics
LENZ
LENZ
63 hedge funds and large institutions have $82M invested in LENZ Therapeutics in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $534K
Holders
63
Holding in Top 10
1
Calls
–
Puts
$534K
Top Buyers
| 1 | +$2.15M | |
| 2 | +$1.24M | |
| 3 | +$1.17M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$1.16M |
| 5 |
Renaissance Technologies
New York
|
+$830K |
Top Sellers
| 1 | -$1.72M | |
| 2 | -$1.35M | |
| 3 | -$453K | |
| 4 |
AC
Aldebaran Capital
Carmel,
Indiana
|
-$322K |
| 5 |
D.E. Shaw & Co
New York
|
-$118K |